[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 2, 1959

ATTENUATED TYPE 1 POLIOVIRUS VACCINEITS CAPACITY TO INFECT AND TO SPREAD FROM "VACCINEES" WITHIN AN INSTITUTIONAL POPULATION

Author Affiliations

New Haven, Conn.

From the Section of Epidemiology and Preventive Medicine, Yale University School of Medicine.

JAMA. 1959;170(1):1-8. doi:10.1001/jama.1959.03010010003001
Abstract

Responses to the oral administration of Sabin's attenuated type 1 poliovirus vaccine were studied in a closed, institutional community under conditions that made it possible to compare individuals whose immunity had been acquired naturally with those who had received the Salk formalinized vaccine. The results showed that all infections induced by the vaccine were symptomless and that they spread readily through the small institutional community. The children whose antibodies had been acquired from the Salk vaccine were easily infected with the attenuated virus, whether they received it by mouth or through contact with individuals infected in the same cottage. In contrast, children whose antibodies had been acquired by previous natural infection were more resistant, but this depended somewhat on the dose of vaccine given. There were indications that passage of the virus through certain individuals slightly increased its neurotropism for the monkey.

×